Compare AVO & EBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AVO | EBS |
|---|---|---|
| Founded | 1983 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Farming/Seeds/Milling | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 818.6M | 663.3M |
| IPO Year | 2020 | 2006 |
| Metric | AVO | EBS |
|---|---|---|
| Price | $13.29 | $12.05 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $17.00 | $15.00 |
| AVG Volume (30 Days) | 961.5K | ★ 968.8K |
| Earning Date | 03-09-2026 | 03-02-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 2.33 | N/A |
| EPS | 0.53 | ★ 1.35 |
| Revenue | ★ $1,391,200,000.00 | $788,900,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $0.57 | $15.21 |
| P/E Ratio | $25.40 | ★ $8.85 |
| Revenue Growth | ★ 12.68 | N/A |
| 52 Week Low | $9.56 | $4.02 |
| 52 Week High | $14.23 | $14.06 |
| Indicator | AVO | EBS |
|---|---|---|
| Relative Strength Index (RSI) | 70.75 | 49.59 |
| Support Level | $10.37 | $10.60 |
| Resistance Level | $14.23 | $12.58 |
| Average True Range (ATR) | 0.52 | 0.79 |
| MACD | 0.16 | -0.15 |
| Stochastic Oscillator | 79.91 | 39.60 |
Mission Produce Inc produces, packs, and distributes mainly Hass avocados to retail, wholesale, and food service customers, offering pre-ripe and ripened fruit tailored to customer specifications through its network of ripening facilities. The Company operates through three segments: Marketing & Distribution, which sources and distributes fruit globally and generates the majority of revenue; International Farming, which owns and operates avocado orchards and supplies fruit mainly to Marketing & Distribution, with operations principally in Peru and Guatemala; and Blueberries, which farms blueberries sold under an exclusive marketing agreement. The Company's operations span Peru, the United States, Guatemala, Mexico, Europe, and Canada.
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. The key revenue is generated through the commercial segment which consists of NARCAN and other commercial products.